Posted by Michael Wonder on 02 May 2023
Medicare’s 'Coverage With Evidence Development': a barrier to patient access and innovation
1 May 2023 - During the George W. Bush administration, the Centers for Medicare and Medicaid Services introduced a program known as “Coverage with Evidence Development” to drive innovation for medical devices by increasing access to new technologies through agency-approved clinical trials.
In practice, it has had much the opposite effect, creating barriers that prevent wider access to medical breakthroughs, limiting data for research, and ultimately hampering innovation.
